Tema ETFs’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
31,270
+201
+0.6% +$12.2K 0.07% 180
2026
Q1
$1.72M Buy
31,069
+8,509
+38% +$458K 0.12% 163
2025
Q4
$1.09M Buy
22,560
+11,585
+106% +$452K 0.08% 225
2025
Q3
$336K Sell
10,975
-429
-4% -$9.85K 0.03% 444
2025
Q2
$253K Buy
+11,404
New +$239K 0.07% 155

Other funds holding ANAB

Tema ETFs's ANAB Position: Q2 2026 in Review

Tema ETFs increased its AnaptysBio (ANAB) stake by 0.65% in Q2 2026, buying an estimated $12.2K and bringing the position to 31,270 shares worth $2.11M. The position accounts for 0.07% of the portfolio, ranked #180.

Tema ETFs first reported a position in ANAB in Q2 2025 and has held it in 5 quarters since. 11 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Tema ETFs held 31,270 shares of AnaptysBio worth $2.11M as of Q2 2026.
  • Tema ETFs bought 201 AnaptysBio shares in Q2 2026, an estimated $12.2K.
  • AnaptysBio made up 0.07% of Tema ETFs's portfolio in Q2 2026, its #180 holding.
  • Tema ETFs first reported a position in AnaptysBio in Q2 2025 and has held it in 5 quarters since.
  • 11 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.